Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Waters

Showing results (191-200 of 198) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 198 results.
Journal of Neurology|November 17, 2022
Clinical pitfalls and serological diagnostics of MuSK myasthenia gravisYoung Nam Kwon, Mark Woodhall, Jung-Joon Sung, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2025
Permissive central tolerance plus defective peripheral checkpoints licence pathogenic memory B cells in CASPR2-antibody encephalitisBo Sun, Dominique Fernandes, Anne-Kathrin Kienzler, et al.
Science Advances|April 16, 2025
Permissive central tolerance plus defective peripheral checkpoints license pathogenic memory B cells in CASPR2-antibody encephalitisBo Sun, Dominique Fernandes, John Soltys, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 27, 2016
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis opticaPatrick Waters, Markus Reindl, Albert Saiz, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 28, 2017
Incidence and prevalence of NMOSD in Australia and New ZealandWajih Bukhari, Kerri M Prain, Patrick Waters, et al.
Frontiers in Neurology|July 3, 2020
Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal VariationElham Khalilidehkordi, Laura Clarke, Simon Arnett, et al.
Journal of Neurology|February 2, 2020
The clinical profile of NMOSD in Australia and New ZealandWajih Bukhari, Laura Clarke, Cullen O'Gorman, et al.
Frontiers in Neurology|September 27, 2021
MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple SclerosisLaura Clarke, Simon Arnett, Wajih Bukhari, et al.
Pageof 20

Showing results (191-200 of 198) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 198 results.
Journal of Neurology|November 17, 2022
Clinical pitfalls and serological diagnostics of MuSK myasthenia gravisYoung Nam Kwon, Mark Woodhall, Jung-Joon Sung, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2025
Permissive central tolerance plus defective peripheral checkpoints licence pathogenic memory B cells in CASPR2-antibody encephalitisBo Sun, Dominique Fernandes, Anne-Kathrin Kienzler, et al.
Science Advances|April 16, 2025
Permissive central tolerance plus defective peripheral checkpoints license pathogenic memory B cells in CASPR2-antibody encephalitisBo Sun, Dominique Fernandes, John Soltys, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 27, 2016
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis opticaPatrick Waters, Markus Reindl, Albert Saiz, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 28, 2017
Incidence and prevalence of NMOSD in Australia and New ZealandWajih Bukhari, Kerri M Prain, Patrick Waters, et al.
Frontiers in Neurology|July 3, 2020
Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal VariationElham Khalilidehkordi, Laura Clarke, Simon Arnett, et al.
Journal of Neurology|February 2, 2020
The clinical profile of NMOSD in Australia and New ZealandWajih Bukhari, Laura Clarke, Cullen O'Gorman, et al.
Frontiers in Neurology|September 27, 2021
MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple SclerosisLaura Clarke, Simon Arnett, Wajih Bukhari, et al.
Pageof 20